|
|
| MRD / Regn No. |
: 20250000192 |
Date |
: 23/06/2026 |
| Patient Name |
: Mani Samuvel |
Age & Gender |
: 56 Yrs. / Male |
| Contact No. |
: 9443629280 |
UHID |
: |
| Ht / Wt / BMI |
: 168.5 / 96.4 / 33.95 |
BP S / BP D |
: 135 / 82 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (14/Mar/2000) | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (14/Mar/2025) | DYSLIPIDEMIA (17/Mar/2025) | |
|
Subjective |
: |
TYPE 2 DM FOR 20 YEARS,FOOT INFECTION FOLLOWING INJURY,ASCVD 2022 |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE,INCREASED FIB4 / NAFLD SCORE,DYSLIPIDEMIA,S2F1 MASLD,VITAMIN D DEFICEINCY |
|
Plan |
: |
INCREASE TIRZEPATIDE TO 5 MG,ADD VITAMIN D,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
VITAMIN D (25 OH): 11.6 ng/mL | FASTING PLASMA GLUCOSE (FPG): 226 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.1 % | POST PRANDIAL GLUCOSE (2HPP): 284 mg/dL | HEMOGLOBIN: 13.5 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 86.6 fL | PLATELETS: 242 thou cells/ ul | VITAMIN B12: 596 pg/mL | WBC WHITE BLOOD CELLS: 894 K/uL | HIGH SENSITIVE C REACTIVE PROTEIN: 0.9 mg/L | BUN BLOOD UREA NITROGEN: 18.4 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 60 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 140 mg/dL | TGL TRIGLYCERIDE: 100 mg/dL | TOTAL CHOLESTEROL: 222 mg/dl | ALBUMIN (SERUM): 4 g/dL | ALKALINE PHOSPHOTASE: 49.3 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 14.9 U/L | SGPT (ALT): 24.1 IU/L | FIB4: 0.70 | TOTAL BILIRUBIN: 0.6 mg/dL | CREATININE: 0.7 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 124.26 mL/min/1.73m2 | UREA: 39.5 mg/dL | URIC ACID: 5.2 | TOTAL T3: 85 | TOTAL T4: 6.5 mcg/dL | TSH : 1.2 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET EMPAGLIFLOZIN 10 MG
COSPIAQ
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTION | |
|
2 |
TABLET ROSUVASTATIN 20 MG
ROSEDAY
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
|
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
3 |
TABLET CLOPIDOGREL 75 MG
PLAVIX 75 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
4 |
INJECTION TIRZEPATIDE 5 MG
MOUNJARO
Medicine For OBESITY DIABETES |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING OR DIARRHEA | |
|
5 |
GEL CHOLECALCIFEROL 60000 IU
ARACHITOL NANO
Medicine For VITAMIN D |
PO |
ONCE A WEEK |
DRINK LIQUID AS IS
|
6 WEEKS |
|
|
6 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 23/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
|
